Effect of ınhaler Use on Oral Health in COPD Patients

Recruiting now · Not applicable

Conditions studied: Chronic Obstructive Pulmonary Disease (COPD)

In brief

The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.

Key facts

Study ID

NCT07000604

Run by

Çankırı Karatekin University

People needed

80

Starts

2025-05-30

Expected to finish

2025-10-30

Last updated by the study team

2025-06-05

Who can join

Age: 35 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with COPD for at least 6 months,
• Outpatient and inpatient,
• Consent to participate in the research,
• Not under the age of eighteen,
• With a metered dose inhaler (MDI) in treatment,
• No communication barriers,
• No COPD exacerbation and/or respiratory tract infection,
• According to the GOLD report; mild (Stage 1), moderate (Stage 2), severe (Stage 3).

You may not qualify if…

• Diagnosed with COPD for less than 6 months,
• Refused to participate in the research,
• Treatment without metered dose inhalers (MDIs),
• Uncommunicative,
• Those who withdrew from participating in the study during data collection,
• Not completing the survey,
• COPD exacerbation and/or respiratory tract infection,

Where it is running

• Çankiri Devlet Hastanesi — Çankırı, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.